Detalhe da pesquisa
1.
Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial.
Mol Psychiatry
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38454079
2.
Bupropion and Naltrexone in Methamphetamine Use Disorder.
N Engl J Med
; 384(2): 140-153, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33497547
3.
Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials.
Br J Psychiatry
; 224(3): 89-97, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38130122
4.
Integration of Measurement-Based Care for Youth Depression and Suicidality Using VitalSign6.
Child Psychiatry Hum Dev
; 2024 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38372870
5.
Characterizing Measurement-Based Care in the Texas Youth Depression and Suicide Research Network (TX-YDSRN).
Child Psychiatry Hum Dev
; 2024 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340213
6.
Alterations in resting-state functional activity and connectivity for major depressive disorder appetite and weight disturbance phenotypes.
Psychol Med
; 53(10): 4517-4527, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35670301
7.
Dysregulation of mitochondrial dynamics, mitophagy and apoptosis in major depressive disorder: Does inflammation play a role?
Mol Psychiatry
; 27(2): 1095-1102, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34650203
8.
Considering depression as a secondary outcome in the optimization of physical activity interventions for breast cancer survivors in the PACES trial: a factorial randomized controlled trial.
Int J Behav Nutr Phys Act
; 20(1): 47, 2023 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37081460
9.
Stigma towards opioid use disorder in primary care remain a barrier to integrating software-based measurement based care.
BMC Psychiatry
; 23(1): 776, 2023 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37875835
10.
AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationale.
BMC Psychiatry
; 23(1): 59, 2023 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36690972
11.
Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial.
Psychol Med
; 52(13): 2441-2449, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33213541
12.
Moderation of buprenorphine therapy for cocaine dependence efficacy by variation of the Prodynorphin gene.
Eur J Clin Pharmacol
; 78(6): 965-973, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35218405
13.
Childhood trauma history is linked to abnormal brain connectivity in major depression.
Proc Natl Acad Sci U S A
; 116(17): 8582-8590, 2019 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30962366
14.
Psychometric Evaluation of the Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire in a General Youth Population.
Child Psychiatry Hum Dev
; 53(3): 546-553, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33713250
15.
Anger attacks are associated with persistently elevated irritability in MDD: findings from the EMBARC study.
Psychol Med
; 51(8): 1355-1363, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32138798
16.
Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis.
Mol Psychiatry
; 25(2): 339-350, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31427752
17.
Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies.
Mol Psychiatry
; 25(7): 1580-1591, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30374191
18.
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).
Mol Psychiatry
; 25(7): 1592-1603, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30283029
19.
Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).
Mol Psychiatry
; 25(7): 1604, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30617276
20.
Discovery and replication of cerebral blood flow differences in major depressive disorder.
Mol Psychiatry
; 25(7): 1500-1510, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31388104